| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
815 |
230 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
261 |
246 |
$22K |
| 80053 |
Comprehensive metabolic panel |
255 |
241 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
13 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
117 |
109 |
$1K |
| 80061 |
Lipid panel |
73 |
73 |
$737.98 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
141 |
124 |
$708.21 |
| 36415 |
Collection of venous blood by venipuncture |
499 |
457 |
$683.86 |
| 84443 |
Thyroid stimulating hormone (TSH) |
37 |
35 |
$502.25 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$464.65 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
68 |
68 |
$314.29 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
13 |
$277.77 |
| 85027 |
|
28 |
27 |
$161.68 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14 |
13 |
$0.03 |